tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 19 are a HOLD (3%), 614 are a BUY (96.85%), 1 are a SELL (0.16%).
Analyst Andrew Fein, carries an average stock price target met ratio of 31.96% that have a potential upside of 54.97% achieved within 173 days. Previously, Andrew Fein worked at HC WAINWRIGHT.
Andrew Fein’s has documented 1,239 price targets and ratings displayed on 59 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 19-May-2025.
Analyst best performing recommendations are on SVRA (SAVARA).
The best stock recommendation documented was for SVRA (SAVARA) at 6/12/2019. The price target of $6 was fulfilled within 1 day with a profit of $4.57 (43.24%) receiving and performance score of 432.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$35
$13.02 (59.24%)
$23
9 days ago
(21-May-2025)
0/4 (0%)
$13.15 (60.18%)
Hold
$24
$2.02 (9.19%)
$20
10 days ago
(20-May-2025)
17/22 (77.27%)
$2.31 (10.65%)
166
Buy
$31
$9.02 (41.04%)
$28
11 days ago
(19-May-2025)
0/4 (0%)
$9.01 (40.97%)
Hold
$23
$1.02 (4.64%)
$20
11 days ago
(19-May-2025)
8/12 (66.67%)
$1.01 (4.59%)
184
Buy
$32
$10.02 (45.59%)
$27
11 days ago
(19-May-2025)
7/22 (31.82%)
$10.01 (45.52%)
118
Which stock is Andrew Fein is most bullish on?
Which stock is Andrew Fein is most reserved on?
What Year was the first public recommendation made by Andrew Fein?
